Prostate Biopsy

1) Defining the Problem 2) WHAT EVERY PATIENT SHOULD KNOW ABOUT PROSTATE CANCER BEFORE HE SUBMITS TO BIOPSY OF HIS PROSTATE Authors: Thomas A. Stamey, MD*, Rosalie Nolley, MD and Dorothea Torti, MD - Stanford University Medical Center - S287, 300 Pasteur Drive, Stanford CA 94305 - tstamey@stanford.edu and tinyn@stanford.edu 3) PSA AND PROSTATE CANCER SCREENING Authors: Stacy Loeb, MD - Department of Urology, Georgetown University, 3800 Reservoir Rd, 4th floor PHC bldg., Washington DC 20007 Misop Han, MD and William J. Catalona, MD* - Department of Urology, Feinberg School of Medicine, Northwestern University, 675 N. St. Clair Suite 20-15, Chicago IL 60611 - wcatalona@nmff.org, wcataona@nmff.org, and stacyloeb@gmail.com 4) THE ROLE OF COMPLEXED PSA (cPSA) IN PROSTATE CANCER SCREENING Authors: Matthew E. Nielsen, MD* and Alan W. Partin, MD, PhD* - Brady Urological Institute, John Hopkins University School of Medicine, Marburg 143, 600 N Wolfe Street, Baltimore MD 21287 - apartin@jhmi.edu and nielsen@jhmi.edu 5) NEWLY RECOGNIZED FORMS OF PSA AND EMERGING MOLECULAR MARKERS Authors: Eduardo I. Canto, MD and Kevin M. Slawin, MD* - Antilles Research Institute, San Juan, PR and Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine - 6560 Fannin Street Suite 2100, Houston TX 77030 - kslawin@bcm.tmc.edu and ecanto@bcm.tmc.edu 6) THE ROLE OF PSA VELOCITY IN THE DIAGNOSIS AND MANAGEMENT OF PROSTATE CANCER Author: H. Ballentine Carter, MD* - James Buchanan Brady Urological Institute, John Hopkins School of Medicine, 600 N. Wolfe St., Baltimore MD 21287 - hcarter@jhmi.edu 7) PROSTATE CANCER SCREENING: NAVIGATING THE CONTROVERSY Authors: Timothy C. Brand, MD* and Ian M. Thompson, MD -Department of Urology, University of Texas Health Science Center, Mail Code 7845, 7703 Floyd Curl Drive, San Antonio TX 78229 - thompsoni@uthscsa.edu, thompsoni@uthscsa.edu and brandt2@uthscsa.edu Chapter Titles/Authors 4/27/2007 Page 2 of 3 8) PROSTATE CANCER NOMOGRAMS AND

Steven Jones, MD, is the Vice Chairman of hte Glickman Urological Institute at the Cleveland Clinic Foundation, one of the foremost departments of urology in the world. He is an expert in many aspects of urological science and medicine and has assembled the greatest international team to address the questions surrounding prostate biopsy.

From the reviews:"20 chapters in this book read as independent articles that delve into many of the most recent discoveries and controversies surrounding prostate cancer diagnosis. ... It presents a good overview of different variations on the PSA blood test and describes the key elements of prostate biopsy. This is a valuable resource for scientists/clinicians who are dedicated to working in the area of prostate cancer diagnosis. ... The chapters provide excellent discussions of their topics and the book is an excellent resource for readers ... ." (Ethan J Halpern, Doody's Review Service, August, 2008)